Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
11.65
Change Change %
0.55 4.95%

Updated:19 Jul, 2019, 15:59 PM IST

BSE
11.68
Change Change %
0.55 4.94%

Updated:19 Jul, 2019, 16:01 PM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

11.50 11.65

52 Wk Range

0.00 11.65
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

11.6711.68

52 Wk Range

0.00 11.68

Compare Price performance of vs. Peer Companies

From sector

Compare with Peers on Key Fundamentals and Financials

Color code for Price performance of and Peer companies

  • 5% and above
  • 2% to 5%
  • 0.5% to 2%
  • -0.5% to 0.5%
  • -2% to -0.5%
  • -5% to -2%
  • -5% and below
 

Lasa Supergenerics's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 26.64
Earning Per Share (EPS TTM) (₹) -5.26
Price To Earnings (P/E) Ratio -2.21
Book Value Per Share (₹) 51.32
Price To Books (P/B) Ratio 0.23
EBIT Margin (%) 10.81
PAT Margin (%) 5.02
ROCE (%) 12.80
PAT Growth (%) 422.35
Total Debt to Equity (D/E) Ratio 0.91

More from Key Fundamentals »

Lasa Supergenerics's Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 22.86 0.05 45628.80%
Total Non-Current Liabilities 62.17 82.76 -24.87%
Total Current Liabilities 107.27 69.99 53.25%
Total Liabilities 286.78 228.25 25.64%
Total Non-Current Assets 177.60 148.84 19.32%
Currents Investments 0.00 0.00 0.00%
Cash and Bank 2.63 1.16 126.68%
Total Current Assets Excluding Current Investments 109.18 79.41 37.50%
Total Assets 286.78 228.25 25.64%
Profit and Loss:
Gross Sales 245.84 218.23 12.65%
Net Sales 243.53 198.75 22.53%
PBIDT (Excl OI) 41.26 45.52 -9.36%
PAT 12.34 2.36 422.35%

More from Financial Summary »

Lasa Supergenerics's Shareholding Pattern

Lasa Supergenerics held by Mutual Fund Schemes

Scheme Holding(%)
No Records Found!

..

Post your comments about Lasa Supergenerics

Top